Advanced Enzyme Technologies Limited Financials: Revenue, Profit, Balance Sheet & Cash Flow

Advanced Enzyme Technologies Limited Score & Ratio Trend

Date	Score	P/E	P/B	D/E	Price
Sep 2026	25,038	19.1	1.91	0.02	283.15
Sep 2026	25,038	19.1	1.91	0.02	283.15
Sep 2026	25,038	19.1	1.91	0.02	283.15
Oct 2026	24,261	18.5	1.85	0.02	274.25
Oct 2026	23,593	18.0	1.80	0.02	267.15

Line Item	Jun 2026	Mar 2026	Dec 2025	Sep 2025
Revenue	1,897,880,000.0	2,033,670,000.0	1,719,490,000.0	1,845,280,000.0
Net Profit	370,930,000.0	429,630,000.0	425,000,000.0	433,260,000.0
EPS	3.3	3.8	3.8	3.9

Line Item	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	7,449,500,000.0	6,365,070,000.0	6,234,770,000.0	5,403,820,000.0
Net Profit	1,687,190,000.0	1,311,150,000.0	1,333,050,000.0	1,056,390,000.0
EPS	15.1	11.7	11.9	9.4

Line Item	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Total Assets	18,387,610,000.0	16,213,470,000.0	15,354,630,000.0	14,218,470,000.0
Total Liabilities	1,556,390,000.0	1,526,770,000.0	1,643,830,000.0	1,376,760,000.0
Total Equity	16,319,570,000.0	14,208,630,000.0	13,241,280,000.0	12,350,690,000.0

Advanced Enzyme Technologies Limited owed ₹0.08 for every ₹1 it owned in Mar 2026, down from ₹0.10 in Mar 2023.

Period	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Owes vs Owns	0.08×	0.09×	0.11×	0.10×

Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.

What it owns — Mar 2026

Cash & short-term investments 38.5%Receivables 7.9%Inventory 9.6%Fixed assets (tangible) 17.8%Intangible assets 22.6%Other assets 3.3%

How it's funded — Mar 2026

Short-term debt 0.7%Payables 2.2%Other liabilities 5.2%Shareholders' equity 91.5%

Line Item	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Assets
Cash & short-term investments	707.2	595.1	548.0	484.3
Receivables	145.0	115.4	98.6	100.3
Inventory	177.3	157.3	148.5	124.0
Fixed assets (tangible)	327.0	314.6	307.3	288.8
Intangible assets	416.4	385.7	383.6	381.7
Long-term investments	5.1	5.6	0.2	0.2
Other assets	60.8	47.6	49.5	42.5
Liabilities & equity
Short-term debt	12.6	12.4	18.2	5.4
Long-term debt	7.9	9.2	7.0	7.8
Payables	40.0	19.5	15.8	24.2
Other liabilities	95.2	111.7	123.5	100.2
Shareholders' equity	1,683.1	1,468.7	1,371.1	1,284.2
Net tangible assets	1,215.6	1,035.1	940.5	853.3

Line Item	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Operating Activities	1,567,760,000.0	1,424,970,000.0	1,413,690,000.0	1,403,620,000.0	—
Investing Activities	-741,300,000.0	-891,010,000.0	-646,490,000.0	-2,981,810,000.0	—
Financing Activities	-703,660,000.0	-725,440,000.0	-592,380,000.0	-257,980,000.0	—